CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). The impact of CKD-MBD on mortality

Masatomo Taniguchi

Research output: Contribution to journalReview article

Abstract

The final goal of CKD-MBD (chronic kidney disease, mineral and bone disorder) is to reduce the risk of death in uremic patients. To achieve this objective, it is of importance to manage laboratory abnormalities, bone abnormalities, and vascular calcification appropriately. Many observation studies suggested that the good control of serum phosphate, calcium, and PTH concentration would lead to the lower risk of death. Fracture and vascular calcification would increase the risk for mortality. In addition, some randomized clinical trials have shown that the use of CKD-MBD related drugs, e.g. vitamin D, phosphate binder, might lead to reductions in the risk of death.

Original languageEnglish (US)
Pages (from-to)1078-1087
Number of pages10
JournalClinical calcium
Volume20
Issue number7
StatePublished - Jul 2010

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). The impact of CKD-MBD on mortality'. Together they form a unique fingerprint.

  • Cite this